Cigarette maker Philip Morris International posted better-than-expected fourth quarter results, driven by strong demand for ...

Philip Morris International Inc. soared to a record after reporting better-than-expected profit driven by sales of Zyn ...

The U.S. Food and Drug Administration (FDA), the US governmental authority responsible for regulating foods and medical ...

(Reuters) -Cigarette maker Philip Morris International on Thursday forecast 2025 profit above estimates after recording ...

Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris ...

The Food and Drug Administration on Thursday authorized the popular Zyn nicotine pouches for sale in the U.S., after studies by the agency determined Philip Morris International’s nicotine ...

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.

Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40 ...

Strong sales of vapes and nicotine pouches helped tobacco giant Philip Morris International beat forecasts with its ...

Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast at www.pmi.com/2024Q4earnings on Thursday, February 6, 2025, at 9:00 a.m. ET, to discuss its 2024 Fourth-Quarter and ...

The nicotine pouch brand's boom came at an opportune time for parent company Philip ... Morris International, which faced a yearslong decline in cigarette smoking. Earlier this month, the Food and ...